Litcius/Paper detail

Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension

Michael T. Eadon, Kerri L. Cavanaugh, Lori A. Orlando, David Christian, Hrishikesh Chakraborty, Kady-Ann Steen-Burrell, Peter Merrill, Janet Seo, Diane Hauser, Rajbir Singh, Cherry Beasley, Jyotsna Fuloria, Heather Kitzman, Alexander S. Parker, Michelle Ramos, Henry H. Ong, Erica N. Elwood, Sheryl Lynch, Sabrina Clermont, Emily J. Cicali, Petr Starostik, Victoria M. Pratt, Khoa A. Nguyen, Marc B. Rosenman, Neil Calman, Mimsie Robinson, Girish N. Nadkarni, Ebony Madden, Natalie Kucher, Simona Volpi, Paul Dexter, Todd C. Skaar, Julie A. Johnson, Rhonda M. Cooper‐DeHoff, Carol R. Horowitz

2022Contemporary Clinical Trials10 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePharmacogenomicsBlood pressureRandomized controlled trialInternal medicineClinical trialSpecialtyKidney diseaseIntensive care medicinePhysical therapyFamily medicinePharmacologyRenal Diseases and GlomerulopathiesCoagulation, Bradykinin, Polyphosphates, and AngioedemaKruppel-like factors research